Senior insider sale
President and COO at CG ONCOLOGY, INC. — senior position signals high conviction
$26.95M
365.99K shares
BELLETE AMBAW plans to sell 365.99K shares of CG ONCOLOGY, INC. valued at approximately $26.95M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Stock Option Exercise
Cash
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/10/2026 | Stock Option Exercise Cash | 50K | — |
| Total | 50K | ||
Completed
Units to sell
9.25K
Market value
$696.1K
Units to sell
75K
Market value
$5.67M
Units to sell
25K
Market value
$1.84M
Units to sell
4.30K
Market value
$316.3K
Units to sell
50K
Market value
$3.63M
Units to sell
50K
Market value
$3.63M
Units to sell
50K
Market value
$3.59M
Units to sell
52.44K
Market value
$3.82M
Planned — Approximate Date
Units to sell
50K
Market value
$3.77M
Units
365.99K
Value
$26.95M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/7/2026 | 9.25K | $696.1K | — | Completed |
8/6/2026 | 75K | $5.67M | — | Completed |
8/5/2026 | 25K | $1.84M | — | Completed |
7/29/2026 | 4.30K | $316.3K | — | Completed |
7/28/2026 | 50K | $3.63M | — | Completed |
7/27/2026 | 50K | $3.63M | — | Completed |
7/23/2026 | 50K | $3.59M | — | Completed |
7/15/2026 | 52.44K | $3.82M | — | Completed |
| Planned — Approximate Date | ||||
8/10/2026 | 50K | $3.77M | NASDAQ | Planned |
| Total | 365.99K | $26.95M | ||